
While reducing the risk of classic fracture, treatment with bisphosphonates may increase the risk of atypical fractures of the femur, with a longer duration of treatment linked to this increasing risk, according to a new study. “We have demonstrated that the association between bisphosphonate treatment and the occurrence of atypical…
Read more »
Bisphosphonates linked to atypical femoral fracture
While reducing the risk of classic fracture, treatment with bisphosphonates may increase the risk of atypical fractures of the femur, with a longer duration of treatment linked to this increasing risk, according to a new study. “We have demonstrated that the association between bisphosphonate treatment and the occurrence of atypical…
Read more »